NCT05797493View on ClinicalTrials.gov

Panomic Approach to Immune-Connected Assays in Small Cell Lung Cancer

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

October 4, 2022

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
Small Cell Lung Cancer
Interventions
DRUG

Atezolizumab

Upfront chemo-immunotherapy

Trial Locations (1)

00168

RECRUITING

Fondazione Policlinico Gemelli IRCCS, Rome

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER